Table 1.
Baseline characteristics and intraoperative data from each group before and after propensity score-matching
| Before matching | After matching | |||||
| Ketamine (+)
n=129 |
Ketamine (–)
n=121 |
P-
value |
Ketamine (+)
n=89 |
Ketamine (–)
n=89 |
P-
value |
|
| Age; years | 65 [55–72] | 67 [55–72] | 0.84 | 65 [55–72] | 64 [54–73] | 0.91 |
| Sex; Male/female | 78/51 | 77/44 | 0.70 | 57/32 | 50/39 | 0.36 |
| BMI; kg/m2 | 22.0 ± 4.3 | 21.2 ± 3.4 | 0.12 | 21.5 ± 3.9 | 21.5 ± 3.5 | 1.00 |
| Operation time; min | 674 ± 118 | 648 ± 115 | 0.09 | 662 ± 119 | 652 ± 120 | 0.56 |
| Anesthesia time; min | 775 ± 120 | 742 ± 120 | 0.03* | 759 ± 118 | 748 ± 127 | 0.53 |
| In-Out balance; mL | 3002 [2250–3776] | 2733 [2192–3800] | 0.45 | 2955 [2067–3748] | 2878 [2114–3800] | 0.95 |
| Blood transfusion | 73 (57%) | 81 (67%) | 0.12 | 53 (60%) | 55 (62%) | 0.88 |
| TIVA with propofol | 6 (5%) | 4 (3%) | 0.75 | 4 (5%) | 3 (3%) | 1.00 |
| NSAIDs (flurbiprofen) | 28 (22%) | 22 (18%) | 0.53 | 15 (17%) | 18 (20%) | 0.70 |
| Free flap reconstruction | 98 (76%) | 85 (70%) | 0.32 | 67 (75%) | 63 (71%) | 0.61 |
| Fentanyl dose; ng/kg/min | 23.8 ± 5.6 | 22.4 ± 6.2 | 0.07 | 22.8 ± 5.5 | 23.3 ± 6.5 | 0.59 |
Values are presented as means ± standard deviations, medians [interquartile ranges], or numbers (proportion, %) of patients.
BMI: body mass index
TIVA: total intravenous anesthesia
NSAIDs: nonsteroidal anti-inflammatory drugs